Commentary: treating alzheimer’s disease : combine or fail ?

Alzheimer’s disease (AD) is the most frequent neurodegenerative disease and accounts for more than 75% of cases of dementia in elderly people. Based on increasing life expectancy, it is predicted that the number of subjects suffering from AD and other dementias will reach the number of 131.5 millions worldwide in 2050 (1).